Publication | Closed Access

Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form

Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryMedicineMonomeric FormDegenerative PathologyProtein MisfoldingHuman NeprilysinNeuropathologyPharmacologyProtein DegradationAmyloid β Peptide